{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:47:20Z","timestamp":1772804840076,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ajo.2014.10.015","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T12:17:30Z","timestamp":1413980250000},"page":"213-220.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Factors Affecting Therapeutic Decisions in Intermediate and Posterior Uveitis"],"prefix":"10.1016","volume":"159","author":[{"given":"Daniel J.","family":"Ozzello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7023","key":"10.1016\/j.ajo.2014.10.015_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence based medicine: what it is and what it isn't","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.ajo.2014.10.015_bib2","first-page":"1435","article-title":"The limits of evidence-based medicine","volume":"46","author":"Tonelli","year":"2001","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ajo.2014.10.015_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2014.10.015_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2014.10.015_bib5","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.ophtha.2014.04.022","article-title":"Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis","volume":"121","author":"Sugar","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2014.10.015_bib6","unstructured":"RED BOOK Online. Greenwood Village, CO: Truven Health Analytics, Inc. Updated Periodically. Available at, http:\/\/sites.truvenhealth.com\/redbook\/online\/. Accessed July 30, 2014."},{"key":"10.1016\/j.ajo.2014.10.015_bib7","series-title":"Physician Fee\u00a0Schedule Search Tool","author":"Centers for Medicare and Medicaid Services","year":"2014"},{"issue":"9","key":"10.1016\/j.ajo.2014.10.015_bib8","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1097\/IAE.0000000000000182","article-title":"Retina specialists treating age-related macular degeneration recommend different approaches for patients than they would choose for themselves","volume":"34","author":"Jeng","year":"2014","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2014.10.015_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12348-011-0047-5","article-title":"Corticosteroid-sparing therapy: practice patterns among uveitis specialists","volume":"2","author":"Esterberg","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"10","key":"10.1016\/j.ajo.2014.10.015_bib10","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"issue":"4-5","key":"10.1016\/j.ajo.2014.10.015_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/08820538.2011.588665","article-title":"The use of biologic agents in the treatment of ocular manifestations of Behcet's disease","volume":"26","author":"Benitah","year":"2011","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2014.10.015_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/ICU.0b013e32834bbe91","article-title":"Ocular Beh\u00e7et disease: current therapeutic approaches","volume":"22","author":"Evereklioglu","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2014.10.015_bib13","first-page":"67","article-title":"Update on the use of systemic biologic agents in the treatment of noninfectious uveitis","volume":"8","author":"Pasadhika","year":"2014","journal-title":"Biologics"},{"issue":"10","key":"10.1016\/j.ajo.2014.10.015_bib14","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.ophtha.2014.04.042","article-title":"Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Beh\u00e7et's disease: A multicenter study","volume":"121","author":"Takeuchi","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2014.10.015_bib15","first-page":"1613","article-title":"Dexamethasone intravitreal implant for the treatment of noninfectious uveitis","volume":"5","author":"Hunter","year":"2011","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2014.10.015_bib16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1517\/14656566.2011.571209","article-title":"Dexamethasone for ocular inflammation","volume":"12","author":"Saraiya","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.ajo.2014.10.015_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/jop.2012.0180","article-title":"A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis","volume":"29","author":"Arcinue","year":"2013","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414006631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414006631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:11:32Z","timestamp":1757596292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939414006631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0002939414006631"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2014.10.015","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Affecting Therapeutic Decisions in Intermediate and Posterior Uveitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2014.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}